Table 2.
Tam vs. control | PgR (IHC) | Number of patients/events | HR (95 % CI) | p value | P for interaction | |
---|---|---|---|---|---|---|
TAM | Control | |||||
Recurrence rate | All | 329/70 | 289/102 | 0.54 (0.40–0.74) | <0.001 | 0.03 |
≥10 % | 225/43 | 182/72 | 0.43 (0.29–0.62) | <0.001 | ||
<10 % | 104/27 | 107/30 | 0.87 (0.52–1.46) | 0.59 | ||
Distant recurrence rate | All | 329/51 | 289/79 | 0.54 (0.38–0.76) | 0.001 | 0.17 |
≥10 % | 225/31 | 182/53 | 0.45 (0.29–0.70) | <0.001 | ||
<10 % | 104/20 | 107/26 | 0.75 (0.42–1.34) | 0.33 | ||
Breast cancer specific mortality rate | All | 329/43 | 289/72 | 0.51 (0.35–0.74) | <0.001 | 0.33 |
≥10 % | 225/26 | 182/47 | 0.44 (0.27–0.71) | 0.001 | ||
<10 % | 104/17 | 107/25 | 0.65 (0.35–1.21) | 0.17 |